Thanks to your generous donations, we are now co-funding pioneering research being undertaken at the world-leading Roslin Institute, the GenOMICC study.
The GenOMICC Study is being led by Dr Kenneth Baillie, Academic Consultant in Critical Care Medicine and Group Leader at the University of Edinburgh’s Roslin Institute. It is a worldwide study that will involve clinicians capturing 100,000 DNA samples from patients in intensive care and high dependency units. In the UK there are over 100 hospitals already taking part and over 1000 intensive care beds, all taking blood and tissue samples which are sent for analysis at The Roslin Institute.
The researchers are comparing the DNA from those who survive sepsis with those who die from the condition to unlock clues to help #StopSepsisNow. For example, what genetic factors may make someone more likely to become critically ill, and which may alter their chance of survival, especially if they’d previously been in good health.
Research has already shown that people who have been adopted are six times more likely to die from infection if their biological parents died of infection; yet the same is not seen with adoptive parents. This suggests that genes are key to us understanding more about sepsis.
New estimates show that twice as many people are dying from sepsis worldwide than previously estimated, so there’s never been a more urgent time to help find a cure for sepsis:
- One in every five deaths worldwide are associated with sepsis
- Two out of every five cases are in children under five
Research is expensive. Significant funding is required to provide our researchers and support staff with the resources needed to carry out their vital work. If you would like to help, there are many ways to get involved in fundraising.
Sepsis Research previously offered small grant funding through The FEATURES Awards but these are now closed as we focus on our research partnership with the Roslin Institute. By focusing our efforts on one major partnership, we feel we can do more to help fight this disease.